Travere Therapeutics
TVTX
#3221
Rank
NZ$8.41 B
Marketcap
NZ$87.67
Share price
-3.86%
Change (1 day)
38.93%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): NZ-$2.27

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$2.34. In 2025 the company made an earnings per share (EPS) of NZ-$0.53 an increase over its 2024 EPS that were of NZ-$7.44.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.27331.47%
2025NZ-$0.53-92.93%
2024NZ-$7.44154.66%
2023NZ-$2.92-63.16%
2022NZ-$7.9344.22%
2021NZ-$5.50-10.09%
2020NZ-$6.12
2018NZ-$4.6164.94%
2017NZ-$2.80
2015NZ$6.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.34-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.72-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA